Form 8-K · Item 4.01 · Auditor change
Crinetics Pharmaceuticals, Inc.: auditor change, BDO USA, P.C. to PricewaterhouseCoopers LLP
Crinetics Pharmaceuticals, Inc. reported in a Form 8-K filed March 3, 2026, that on February 27, 2026, BDO USA, P.C. was dismissed as its certifying accountant, and PricewaterhouseCoopers LLP was engaged. The filing reports no disagreements with the former accountant.
In the filing's words
On February 27, 2026, the Audit Committee (the "Audit Committee") of the Board of Directors of Crinetics Pharmaceuticals, Inc. (the "Company") approved the dismissal of BDO USA, P.C. ("BDO") as the Company’s independent registered public accounting firm.
there were no disagreements (as defined in Item 304(a)(1)(iv) of Regulation S-K) between the Company and BDO on any matters of accounting principles or practices, financial statement disclosure, or auditing scope or procedures
On February 27, 2026, the Audit Committee approved the appointment of PricewaterhouseCoopers LLP (“PwC”) as the Company’s new independent registered public accounting firm for the fiscal year ended December 31, 2026.
Verbatim from sec.gov, Item 4.01 (Changes in Registrant's Certifying Accountant). We quote the filing; we do not characterize it.
| Company | Crinetics Pharmaceuticals, Inc. |
|---|---|
| Ticker | CRNX |
| Form and item | 8-K, Item 4.01 |
| Filed with the SEC | March 3, 2026 |
| What the filing states | dismissed, engaged |
| Former accountant | BDO USA, P.C. |
| New accountant | PricewaterhouseCoopers LLP |
| Date of the change | February 27, 2026 |
| Disagreements | none reported |
| Auditor's letter | Exhibit 16 on sec.gov |
| Accession number | 0001658247-26-000017 |
| SEC CIK | 0001658247 |
Crinetics Pharmaceuticals, Inc. reported under Form 8-K Item 4.01 (Changes in Registrant's Certifying Accountant), filed March 3, 2026. The filing's own words are quoted above.
Sources
More: all auditor changes · Something wrong? Send a correction with the primary source.